AGILE THERAPEUTICS INC (47) | Stock Agreements (6)
Recent Contracts
-
Common Stock Sales Agreement dated April 27, 2022 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on April 27, 2022)
-
Common Stock Sales Agreement dated March 18, 2021 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on March 18, 2021)
-
Description of Capital Stock
(Filed With SEC on February 20, 2020)
-
Common Stock Sales Agreement dated November 8, 2019 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on November 8, 2019)
-
Stock Purchase Agreement, dated as of March 4, 2019, by and among Agile Therapeutics, Inc. and the Purchasers Named Therein
(Filed With SEC on March 4, 2019)
-
Common Stock Sales Agreement dated January 23, 2019 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on January 23, 2019)
